Sensei Biotherapeutics (NASDAQ:SNSE) Shares Down 1.3% – Time to Sell?

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE)’s share price fell 1.3% during mid-day trading on Wednesday . The company traded as low as $0.44 and last traded at $0.46. 37,044 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 114,842 shares. The stock had previously closed at $0.47.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a “buy” rating and set a $4.00 price objective on shares of Sensei Biotherapeutics in a report on Wednesday, August 7th.

Sensei Biotherapeutics Stock Performance

The firm has a fifty day moving average of $0.55 and a 200-day moving average of $0.79. The company has a quick ratio of 10.90, a current ratio of 10.90 and a debt-to-equity ratio of 0.01. The firm has a market cap of $11.51 million, a P/E ratio of -0.38 and a beta of 0.03.

Sensei Biotherapeutics (NASDAQ:SNSE) last issued its earnings results on Tuesday, August 6th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.01. Research analysts predict that Sensei Biotherapeutics, Inc. will post -1.11 earnings per share for the current fiscal year.

About Sensei Biotherapeutics

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.